Root Financial Partners
NBIX icon

Root Financial Partners’s Neurocrine Biosciences NBIX Stock Holding History

Root Financial Partners’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$147K Sell
1,034
-443
-30% -$71.2K ﹤0.01% 569
2026
Q2 		$249K Buy
1,477
+323
+28% +$47.9K 0.01% 329
2026
Q1 		$152K Buy
1,154
+955
+480% +$127K 0.01% 412
2025
Q4 		$28.2K Buy
199
+26
+15% +$3.77K ﹤0.01% 983
2025
Q3 		$24.3K Buy
+173
New +$23.4K ﹤0.01% 1017

Other funds holding NBIX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $102B AUM 35.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Root Financial Partners's NBIX Position: Q3 2026 in Review

Root Financial Partners reduced its Neurocrine Biosciences (NBIX) stake by 30% in Q3 2026, selling an estimated $71.2K and leaving 1,034 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #569.

Root Financial Partners first reported a position in NBIX in Q3 2025 and has held it in 5 quarters since. The position peaked at $249K in Q2 2026. 630 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.

  • Root Financial Partners held 1,034 shares of Neurocrine Biosciences worth $147K as of Q3 2026.
  • Root Financial Partners sold 443 Neurocrine Biosciences shares in Q3 2026, an estimated $71.2K.
  • Neurocrine Biosciences made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #569 holding.
  • Root Financial Partners first reported a position in Neurocrine Biosciences in Q3 2025 and has held it in 5 quarters since.
  • Root Financial Partners's Neurocrine Biosciences position peaked at $249K in Q2 2026.
  • 630 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.